Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst S.r.l. Irccs
Clinical trials sponsored by Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori Irst S.r.l. Irccs, explained in plain language.
-
Can your phone help you beat cancer? app aims to keep patients on track
Disease control CompletedThis study tested whether a smartphone app could help cancer patients remember to take their oral medications better than a traditional paper diary. It involved 124 adults with various cancers who were prescribed pill-based treatments. Researchers compared the two methods to see …
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Researchers track how doctors provide comfort care for seriously ill patients
Knowledge-focused CompletedThis study observed 178 patients with advanced cancer, lung disease, or kidney failure to understand when and how palliative care (comfort-focused treatment) should be provided alongside regular medical care. Researchers tracked patients' standard treatment without changing it, a…
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Researchers look back at leukemia treatment results
Knowledge-focused CompletedThis study collected information from 84 patients who had already received a targeted leukemia drug called anti-CD22 between 2014 and 2019. The goal was to learn more about how safe and effective the treatment was in everyday medical practice, outside of formal clinical trials. R…
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC